Moderna Lifts Annual Revenue Forecast on Strong COVID Vaccine Demand Overseas
Moderna raised its full-year revenue forecast following a profitable third quarter driven by strong international COVID vaccine demand. The company also highlighted FDA clearance for its flu vaccine a
reuters · 2026-11-06 03:50 UTC